Yahoo Finance • last month
[Blood sample for Alzheimer test] jarun011/iStock via Getty Images * Shares of Quanterix Corp. are up ~4% in Wednesday morning trading after CMS' recently released preliminary Clinical Lab Fee Schedule listed the company's LucentAD Alzh... Full story
Yahoo Finance • 2 months ago
Investing.com - Canaccord Genuity downgraded Quanterix Corp. (NASDAQ:QTRX) from Buy to Hold and slashed its price target to $5.00 from $12.00, citing lack of near-term visibility and catalysts. The stock has already fallen over 21% in th... Full story
Yahoo Finance • 2 months ago
* Quanterix press release [https://seekingalpha.com/pr/20194280-quanterix-releases-financial-results-for-the-second-quarter-of-2025] (NASDAQ:QTRX [https://seekingalpha.com/symbol/QTRX]): Q2 GAAP EPS of -$0.77 misses by $0.36. * Revenue... Full story
Yahoo Finance • 2 months ago
At Holdings Channel, we have reviewed the latest batch of the 43 most recent 13F filings for the 06/30/2024 reporting period, and noticed that Vanguard Index Funds Mid-Cap Value Index VIPER Shs (Symbol: VB) was held by 19 of these funds.... Full story
Yahoo Finance • 3 months ago
Quanterix Corp (NASDAQ:QTRX), a life sciences company with annual revenue of $135.69 million, reported Monday that it has committed to a plan to terminate certain executives at its recently acquired subsidiary, Akoya Biosciences, Inc. The... Full story
Yahoo Finance • 3 months ago
BILLERICA, Mass., July 11, 2025--(BUSINESS WIRE)--Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced that on July 8, 2025... Full story
Yahoo Finance • 3 months ago
(RTTNews) - Quanterix Corporation (QTRX), a leader in ultra-sensitive biomarker detection, has completed its acquisition of Akoya Biosciences, Inc., a strategic move that positions the combined company as a leading force in early disease d... Full story
Yahoo Finance • 3 months ago
Quanterix Corporation (NASDAQ:QTRX) has completed its acquisition of Akoya Biosciences , Inc. (NASDAQ:AKYA), a company with a market capitalization of $64.4 million and annual revenue of approximately $80 million, according to a statemen... Full story
Yahoo Finance • 3 months ago
BILLERICA, Mass. - Quanterix Corporation (NASDAQ:QTRX) announced Tuesday it has completed its previously announced acquisition of Akoya Biosciences, Inc., creating what the company describes as a scaled leader in early disease detection fo... Full story
Yahoo Finance • 4 months ago
[Wide Angle Shot of a Clean and Organized Modern Laboratory] Tom Werner * Several life sciences tools companies closed noticably higher Wednesday following a report that the NIH has issued a memo not to cancel funding for any more resea... Full story
Yahoo Finance • 4 months ago
BILLERICA, Mass. - Quanterix Corporation (NASDAQ:QTRX), a medical technology company with a market capitalization of $237.64 million, announced Monday that its HD-X Simoa Immunoassay Analyzer has received Class 1 Medical Device registratio... Full story
Yahoo Finance • 4 months ago
Canaccord Genuity reiterated its Buy rating and $12.00 price target on Quanterix Corp. (NASDAQ:QTRX) following discussions with the company’s management about growth drivers and its pending merger with Akoya. According to InvestingPro da... Full story
Yahoo Finance • 4 months ago
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. On Monday, AppFolio's, Timothy K. Bliss, ma... Full story
Yahoo Finance • 6 months ago
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Service... Full story
Yahoo Finance • 6 months ago
NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services... Full story
Yahoo Finance • 7 months ago
MARLBOROUGH, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the fourth quarter and full year ending December 31, 2024.... Full story
Yahoo Finance • 8 months ago
NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Quanterix Corporation (NASDAQ:QTRX), e.l.f. Beauty, Inc. (NYSE: ELF),... Full story
Yahoo Finance • 8 months ago
NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Quanterix Corporation (NASDAQ: QTRX) resulting from al... Full story
Yahoo Finance • 8 months ago
NEW YORK, Feb. 17, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story
Yahoo Finance • 8 months ago
NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report.... Full story